FCBT
CPRX icon

First Citizens Bank & Trust’s Catalyst Pharmaceutical CPRX Stock Holding History

First Citizens Bank & Trust’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718K Buy
22,851
+1,967
+9% +$58.1K 0.01% 378
2026
Q1 		$517K Sell
20,884
-169
-0.8% -$4.03K 0.01% 430
2025
Q4 		$491K Sell
21,053
-56
-0.3% -$1.25K 0.01% 448
2025
Q3 		$416K Sell
21,109
-2,577
-11% -$53K 0.01% 470
2025
Q2 		$514K Buy
+23,686
New +$559K 0.01% 427

Other funds holding CPRX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
OLA
Oliver Luxxe Assets Gladstone, New Jersey $679M AUM 47.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
PA
Procyon Advisors Shelton, Connecticut $2.32B AUM 26.81% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
HNB
Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return